Immunoassays are laboratory techniques used to detect and measure specific substances, including antibodies, antigens, hormones, proteins, drugs, and disease-related biomarkers. These tests use the specific binding properties of antibodies to identify target substances in biological samples. They are widely applied in clinical diagnostics, infectious disease screening, endocrinology, cardiology, oncology, autoimmune disease testing, reproductive health, and pharmaceutical research.
According to Fortune Business Insights, the global immunoassay market size was valued at USD 26.80 billion in 2025. The market is projected to grow from USD 28.81 billion in 2026 to USD 51.80 billion by 2034, exhibiting a CAGR of 7.6% during the forecast period. North America dominated the immunoassay market with a market share of 33.76% in 2025.
Increasing Adoption of Biomarker-Based Diagnosis: The growing use of biomarkers in disease diagnosis and monitoring is a major factor supporting market expansion. Immunoassays help healthcare professionals detect and monitor infectious diseases, thyroid disorders, cardiac conditions, cancer markers, autoimmune diseases, and neurological conditions. Their ability to support repeated testing and clinical monitoring makes them valuable across hospitals, diagnostic laboratories, and outpatient facilities.
Growing Demand for Automated Laboratory Testing: Healthcare facilities are increasingly adopting automated and high-throughput immunoassay platforms to manage rising diagnostic workloads. Automated systems streamline sample handling, reagent dispensing, detection, and result interpretation. These capabilities help laboratories improve productivity, reduce manual intervention, and support consistent testing processes.
Expansion of Point-of-Care and Home-Based Testing: The development of convenient diagnostic solutions is creating opportunities for immunoassay manufacturers. Point-of-care testing can support faster clinical decisions, while home-based testing offers additional convenience for selected diagnostic applications. These approaches are contributing to the expansion of immunoassay use beyond conventional laboratory settings.
High Instrument and Reagent Costs: The substantial investment required for analyzers, proprietary reagents, calibrators, maintenance, and trained personnel can restrict adoption, particularly among smaller laboratories and healthcare facilities in resource-limited markets. Regulatory requirements and the need for quality-control procedures also increase operational expenses.
Assay Interference and Standardization Challenges: Cross-reactivity, sample-related interference, calibration differences, and limited standardization can affect the comparability of results across testing platforms. Manufacturers and laboratories must maintain analytical accuracy and conduct appropriate validation and quality-control procedures to support reliable testing.